These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1311 related articles for article (PubMed ID: 20562913)

  • 41. Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling.
    Kwon GT; Cho HJ; Chung WY; Park KK; Moon A; Park JH
    J Nutr Biochem; 2009 Sep; 20(9):663-76. PubMed ID: 18824345
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FMNL2 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
    Li Y; Zhu X; Zeng Y; Wang J; Zhang X; Ding YQ; Liang L
    Mol Cancer Res; 2010 Dec; 8(12):1579-90. PubMed ID: 21071512
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EGF‑stimulated AKT activation is mediated by EGFR recycling via an early endocytic pathway in a gefitinib‑resistant human lung cancer cell line.
    Nishimura Y; Takiguchi S; Ito S; Itoh K
    Int J Oncol; 2015 Apr; 46(4):1721-9. PubMed ID: 25653196
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Celecoxib inactivates epithelial-mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cells.
    Bocca C; Bozzo F; Cannito S; Parola M; Miglietta A
    Mol Carcinog; 2012 Oct; 51(10):783-95. PubMed ID: 21882253
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Suppression of EGF-induced tumor cell migration and matrix metalloproteinase-9 expression by capsaicin via the inhibition of EGFR-mediated FAK/Akt, PKC/Raf/ERK, p38 MAPK, and AP-1 signaling.
    Hwang YP; Yun HJ; Choi JH; Han EH; Kim HG; Song GY; Kwon KI; Jeong TC; Jeong HG
    Mol Nutr Food Res; 2011 Apr; 55(4):594-605. PubMed ID: 21462327
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intestinal epithelial cancer cell anoikis resistance: EGFR-mediated sustained activation of Src overrides Fak-dependent signaling to MEK/Erk and/or PI3-K/Akt-1.
    Demers MJ; Thibodeau S; Noël D; Fujita N; Tsuruo T; Gauthier R; Arguin M; Vachon PH
    J Cell Biochem; 2009 Jul; 107(4):639-54. PubMed ID: 19479902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Down-regulation of MEK/ERK signaling by E-cadherin-dependent PI3K/Akt pathway in differentiating intestinal epithelial cells.
    Laprise P; Langlois MJ; Boucher MJ; Jobin C; Rivard N
    J Cell Physiol; 2004 Apr; 199(1):32-9. PubMed ID: 14978732
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.
    Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH
    Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stearoyl-CoA desaturase activity modulates the activation of epidermal growth factor receptor in human lung cancer cells.
    Nashed M; Chisholm JW; Igal RA
    Exp Biol Med (Maywood); 2012 Sep; 237(9):1007-17. PubMed ID: 22946088
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidermal growth factor and hepatocyte growth factor cooperate to enhance cell proliferation, scatter, and invasion in murine mammary epithelial cells.
    Accornero P; Miretti S; Starvaggi Cucuzza L; Martignani E; Baratta M
    J Mol Endocrinol; 2010 Feb; 44(2):115-25. PubMed ID: 19850646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Snail regulated by PKC/GSK-3β pathway is crucial for EGF-induced epithelial-mesenchymal transition (EMT) of cancer cells.
    Liu ZC; Chen XH; Song HX; Wang HS; Zhang G; Wang H; Chen DY; Fang R; Liu H; Cai SH; Du J
    Cell Tissue Res; 2014 Nov; 358(2):491-502. PubMed ID: 25124796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
    Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR
    Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stimulated PI3K-AKT signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activity.
    Toulany M; Baumann M; Rodemann HP
    Mol Cancer Res; 2007 Aug; 5(8):863-72. PubMed ID: 17699110
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Snail promotes cell migration through PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent pathways during prostate cancer progression.
    Henderson V; Smith B; Burton LJ; Randle D; Morris M; Odero-Marah VA
    Cell Adh Migr; 2015; 9(4):255-64. PubMed ID: 26207671
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway.
    Liang L; Li L; Zeng J; Gao Y; Chen YL; Wang ZQ; Wang XY; Chang LS; He D
    Oncol Rep; 2012 Sep; 28(3):999-1005. PubMed ID: 22736024
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Crosstalk of EGF-directed MAPK signalling pathways and its potential role on EGF-induced cell proliferation and COX-2 expression in human mesenchymal stem cells.
    Sabri A; Ziaee AA; Ostad SN; Alimoghadam K; Ghahremani MH
    Cell Biochem Funct; 2011; 29(1):64-70. PubMed ID: 21264892
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Taiwan cobra cardiotoxin III suppresses EGF/EGFR-mediated epithelial-to-mesenchymal transition and invasion of human breast cancer MDA-MB-231 cells.
    Tsai PC; Fu YS; Chang LS; Lin SR
    Toxicon; 2016 Mar; 111():108-20. PubMed ID: 26774845
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Down-regulation of 3-phosphoinositide-dependent protein kinase-1 levels inhibits migration and experimental metastasis of human breast cancer cells.
    Liu Y; Wang J; Wu M; Wan W; Sun R; Yang D; Sun X; Ma D; Ying G; Zhang N
    Mol Cancer Res; 2009 Jun; 7(6):944-54. PubMed ID: 19531564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
    Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
    Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tissue kallikrein promotes prostate cancer cell migration and invasion via a protease-activated receptor-1-dependent signaling pathway.
    Gao L; Smith RS; Chen LM; Chai KX; Chao L; Chao J
    Biol Chem; 2010 Jul; 391(7):803-12. PubMed ID: 20482314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 66.